481 related items for PubMed ID: 27544322
1. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):396-406. PubMed ID: 27544322
[Abstract] [Full Text] [Related]
2. Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia.
Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2018 Apr; 178():221-228. PubMed ID: 29277706
[Abstract] [Full Text] [Related]
3. Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia.
Kamrath C, Hartmann MF, Pons-Kühnemann J, Wudy SA.
Metabolism; 2020 Nov; 112():154354. PubMed ID: 32916150
[Abstract] [Full Text] [Related]
4. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
Jones CM, Mallappa A, Reisch N, Nikolaou N, Krone N, Hughes BA, O'Neil DM, Whitaker MJ, Tomlinson JW, Storbeck KH, Merke DP, Ross RJ, Arlt W.
J Clin Endocrinol Metab; 2017 Jun 01; 102(6):1797-1806. PubMed ID: 27845856
[Abstract] [Full Text] [Related]
5. Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency.
Pussard E, Travers S, Bouvattier C, Xue QY, Cosson C, Viengchareun S, Martinerie L, Lombès M.
J Steroid Biochem Mol Biol; 2020 Apr 01; 198():105553. PubMed ID: 31778802
[Abstract] [Full Text] [Related]
6. Metabotypes of congenital adrenal hyperplasia in infants determined by gas chromatography-mass spectrometry in spot urine.
Kamrath C, Friedrich C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2023 Jul 01; 231():106304. PubMed ID: 36990162
[Abstract] [Full Text] [Related]
7. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM, Stepien KM, Krishan A.
Cochrane Database Syst Rev; 2020 Mar 19; 3(3):CD012517. PubMed ID: 32190901
[Abstract] [Full Text] [Related]
8. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W, Schwarz HP.
Horm Res Paediatr; 2011 Mar 19; 75(4):264-8. PubMed ID: 21196707
[Abstract] [Full Text] [Related]
9. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 19; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
10. Characteristics of Growth in Children With Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency During Adrenarche and Beyond.
Troger T, Sommer G, Lang-Muritano M, Konrad D, Kuhlmann B, Zumsteg U, Flück CE.
J Clin Endocrinol Metab; 2022 Jan 18; 107(2):e487-e499. PubMed ID: 34599587
[Abstract] [Full Text] [Related]
11. Height Velocity Defined Metabolic Control in Children With Congenital Adrenal Hyperplasia Using Urinary Steroid GC-MS Analysis.
Kamrath C, Wettstaedt L, Hartmann MF, Wudy SA.
J Clin Endocrinol Metab; 2019 Sep 01; 104(9):4214-4224. PubMed ID: 31112272
[Abstract] [Full Text] [Related]
12. Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
Clausen CS, Ljubicic ML, Main KM, Andersson AM, Petersen JH, Frederiksen H, Duno M, Johannsen TH, Juul A.
Horm Res Paediatr; 2020 Sep 01; 93(4):226-238. PubMed ID: 33017824
[Abstract] [Full Text] [Related]
13. Long-term Growth in Congenital Adrenal Hyperplasia.
Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A.
Indian J Pediatr; 2019 Feb 01; 86(2):154-158. PubMed ID: 30097840
[Abstract] [Full Text] [Related]
14. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Öhl L, Rauh M, Schöfl C, Dörr HG.
Horm Res Paediatr; 2011 Feb 01; 76(6):400-10. PubMed ID: 22123283
[Abstract] [Full Text] [Related]
15. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Clin Endocrinol Metab; 2002 May 01; 87(5):2238-44. PubMed ID: 11994370
[Abstract] [Full Text] [Related]
16. Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/ tetrahydroxycortisone ratio and 11β-hydroxyandrosterone.
Koyama Y, Homma K, Fukami M, Miwa M, Ikeda K, Ogata T, Hasegawa T, Murata M.
Clin Chem; 2012 Apr 01; 58(4):741-7. PubMed ID: 22273564
[Abstract] [Full Text] [Related]
17. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J, Aldridge S, Thomas M, Cheetham T.
J Pediatr Endocrinol Metab; 2018 Sep 25; 31(9):1019-1022. PubMed ID: 30173205
[Abstract] [Full Text] [Related]
18. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I, Cutler GB.
Clin Endocrinol (Oxf); 1999 Sep 25; 51(3):285-91. PubMed ID: 10469007
[Abstract] [Full Text] [Related]
19. Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis.
Kamrath C, Hochberg Z, Hartmann MF, Remer T, Wudy SA.
J Clin Endocrinol Metab; 2012 Mar 25; 97(3):E367-75. PubMed ID: 22170725
[Abstract] [Full Text] [Related]
20. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2007 May 25; 92(5):1635-9. PubMed ID: 17299071
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
